Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

202282 citationsJournal Articlehybrid Open Access

Authors

Linda-Gail Bekker

Nigel Garrett · University of KwaZulu-Natal

Ameena Goga

Lara Fairall

Tarylee Reddy · South African Medical Research Council

Nonhlanhla Yende-Zuma · Centre for the AIDS Programme of Research in South Africa

Ishen Seocharan · South African Medical Research Council

Abstract

National Treasury of South Africa, the National Department of Health, Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation, and the Bill & Melinda Gates Foundation.

Topics & Keywords

Vaccine Coverage and Hesitancy SARS-CoV-2 and COVID-19 Research Immune responses and vaccinations

Publication Details

Published in: The Lancet

Volume 399, Issue 10330, pp. 1141-1153

DOI: 10.1016/s0140-6736(22)00007-1

Field-Weighted Citation Impact: 13.14

Command Palette

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

Authors

Abstract

Topics & Keywords

Publication Details